GHK-Cu is the only well-characterized peptide-copper complex in routine research use. The tripeptide Gly-His-Lys binds a single Cu²⁺ ion in a square-planar geometry, producing a compound whose chemistry, color, and biology all depend on the copper bond staying intact. This article covers what the molecule actually is, why the visible blue color is an analytical signal rather than a cosmetic feature, and the storage and handling considerations specific to a copper-coordinating peptide.
Structural identity
- Sequence:
GHK(glycyl-L-histidyl-L-lysine, 3 amino acids) - Free GHK molecular formula: C₁₄H₂₆N₆O₄
- Free GHK average mass: 340.38 g/mol
- GHK-Cu complex average mass: 402.91 g/mol — the difference accounts for the bound Cu²⁺ ion and the deprotonation that accompanies complex formation.
- Origin: Endogenous human plasma tripeptide, first isolated by Loren Pickart at the University of California, San Francisco, in 1973. The commercial material is synthesized chemically and complexed with copper after purification.
The three residues each contribute donor atoms to the copper coordination sphere: the terminal α-amine of glycine, the deprotonated amide nitrogen of the Gly-His peptide bond, and the imidazole side chain of histidine. The lysine ε-amine sits outside the coordination sphere and remains free at physiological pH — it is the most common site for cosmetic or analytical chemical modification of the molecule.
The copper coordination: what makes this not just a tripeptide
Cu²⁺ in GHK-Cu sits in a square-planar coordination geometry with three nitrogen donors from the peptide and a fourth, more loosely held axial donor that in aqueous solution is typically water or a counter-ion. The geometry is characteristic of d⁹ Cu²⁺ complexes and is what gives the molecule its distinctive chemistry.
Three features of the coordination are worth flagging:
- Deprotonated peptide nitrogen. The amide nitrogen between glycine and histidine donates only after losing its proton. This is unusual in normal peptide chemistry, where amide nitrogens are not basic enough to coordinate without metal-assisted deprotonation. Bound Cu²⁺ lowers the apparent pKa enough to make this happen at physiological pH.
- High binding affinity. Log K for the GHK-Cu complex is approximately 16.4 at pH 7.4. This puts GHK in direct competition with serum albumin (log K ~16.2 for the N-terminal Cu²⁺ binding site) for circulating copper in plasma — the two are essentially equipotent copper carriers, and free GHK in vivo exists as a Cu²⁺-loaded complex almost by default.
- Redox-accessible copper. The bound copper retains some redox activity and can cycle between Cu(II) and Cu(I) under reducing conditions. This is mechanistically relevant to the molecule's biology and is the reason GHK-Cu is sensitive to reducing agents in solution.
Where GHK-Cu comes from in plasma chemistry
Loren Pickart's 1973 dissertation work isolated the GHK sequence as the active component of a plasma fraction that restored "young"-cell-typical responses in cultured hepatocytes from older donors. The molecule is not a designed analog or a fragment of a larger therapeutic; it is a native human plasma peptide whose biology is tied to normal copper trafficking and tissue homeostasis.
Two facts about endogenous GHK-Cu set the context for research use:
- Plasma concentration declines with age. Published measurements report roughly 200 ng/mL in early adulthood, declining to roughly 80 ng/mL by the sixth decade. The decline is approximately linear with age and is the historical motivation for studying exogenous GHK-Cu in skin, connective-tissue, and wound-healing research.
- Local concentrations rise after tissue injury. GHK levels in wound exudate rise sharply during the inflammatory and proliferative phases of healing, consistent with a role in copper delivery and signaling at the injury site.
These two observations — endogenous presence and injury-responsive elevation — frame most of the preclinical work that followed.
Published research scope
The GHK-Cu literature spans five overlapping preclinical research areas:
- Dermal fibroblast biology. Pickart and Lovejoy's 1987 work characterized stimulated collagen and glycosaminoglycan synthesis in cultured human fibroblasts. Maquart and colleagues at Reims followed in the early 1990s with detailed dose-response and matrix-protein-secretion work.
- Wound healing in rodent models. Mulder et al. (1994) and subsequent work characterized granulation tissue formation, contraction kinetics, and tensile strength endpoints in rat and rabbit wound models.
- Hair follicle biology. Uno and Kurata reported follicular changes in murine models in the early 1990s; later work in human follicular organ culture extended these findings.
- Ex vivo human skin. A 2000s-era body of dermatology research applied GHK-Cu to skin explant cultures and quantified barrier protein expression, elastin and collagen markers, and antioxidant gene response.
- Gene-expression profiling. Hong, Pickart, and colleagues' Connectivity Map analysis (2015) reported that GHK exposure produced gene-expression signatures overlapping with cellular reset and DNA repair pathways. This is the work most often cited in newer GHK research.
Controlled human clinical-trial data remain limited; the bulk of published evidence is in vitro on human cells or in vivo in non-primate animal models. Researchers should approach the broader claim landscape critically, particularly older marketing-adjacent literature that conflates in vitro fibroblast findings with in vivo human outcomes.
Why is GHK-Cu blue?
The Cu²⁺ ion at the center of the GHK-Cu complex has an unfilled d-orbital that absorbs visible light in the 520–540 nm band, producing the deep cobalt blue color seen in the vial. The color is not a dye and is not contributed by the peptide itself; free GHK is colorless. The blue is direct optical evidence that the copper coordination is intact.
Two practical consequences follow:
- Color is a free analytical check. A fresh lot of GHK-Cu, lyophilized or reconstituted, should be visibly blue at the milligram-per-mL scale. Faded color or a colorless solution indicates the copper has dissociated — through acid hydrolysis, displacement by a stronger chelator in the buffer, or reduction to Cu(I). The material is no longer GHK-Cu at that point, even if the peptide backbone is intact.
- Color saturation is non-linear. The d-d transition has a relatively low molar absorptivity (around 100 M⁻¹·cm⁻¹), but at the concentrations typical for research use the color appears intense. Some researchers interpret deep blue as "too concentrated"; it is not. Color saturates visually at concentrations well below practical working stocks and is not a guide to molar concentration.
Stability and the copper bond
In the lyophilized state, GHK-Cu is stable for years if cold storage is maintained:
- Refrigerated (2–8°C): 24 months as a sealed lyophilized vial is the standard manufacturer specification.
- Frozen (−20°C): 36+ months. Internal stability data show negligible HPLC drift at this storage temperature for sealed vials.
Reconstituted in bacteriostatic water at neutral pH and refrigerated, working stocks typically remain within spec for 2–4 weeks. The benzyl alcohol bacteriostat at the 0.9% concentration used in standard BAC water is compatible with the copper complex and does not interfere with the coordination chemistry.
Two stability factors are specific to copper-peptide chemistry and worth spelling out:
What dissociates the complex:
- Acidic buffers (pH < 4). Protonation of the donor nitrogens dissociates the complex. Do not mix GHK-Cu into trifluoroacetic acid, citric acid, or other low-pH formulations.
- Strong reducing agents. Glutathione, DTT, β-mercaptoethanol, and high concentrations of ascorbate reduce Cu(II) to Cu(I), which has different coordination preferences and dissociates from the GHK scaffold.
- Competing chelators. EDTA, EGTA, and similar polyaminocarboxylates have higher copper affinity than GHK and will strip the copper. Avoid these in any buffer that contacts GHK-Cu.
Light sensitivity is less critical for GHK-Cu than for tryptophan-containing peptides — GHK has no aromatic photoreactive residues — but the d-d transition itself can photoexcite the complex under extended UV exposure. Foil-wrap of refrigerated vials is sufficient. The broader framework for cold storage, freeze-thaw, and oxidation is covered in our storage and stability article.
Reconstitution and color as a visual check
GHK-Cu reconstitutes the same way most lyophilized peptides do — diluent against the glass wall, gentle swirl, no shaking. The full protocol in our reconstitution guide applies unchanged. Three specifics are worth noting for this compound:
- The lyophilized cake is already blue. The 50 mg and 100 mg vials in our catalog arrive as a deeply colored cake or film. The color in the dry state is the same Cu²⁺ d-d transition responsible for the solution color; it is not a dye and not a sign of contamination.
- Dissolution is fast. GHK-Cu is highly water-soluble and cakes typically dissolve in under 30 seconds of gentle swirling. Slow dissolution usually means the diluent stream hit the cake directly and aerosolized material onto the stopper.
- Solubility ceiling is generous. GHK-Cu is comfortably soluble at 10 mg/mL or higher in water. Most laboratory work uses 1–5 mg/mL solutions, well below any solubility constraint.
Once reconstituted, the solution should be a clear deep blue with no visible particulates. A colorless or pale reconstituted solution is a red flag and should be investigated against the lot's CoA before further use.
Common analytical and handling issues
HPLC: free GHK versus GHK-Cu
Free GHK and the Cu²⁺ complex elute at different retention times under standard RP-HPLC conditions — the complex is more polar and elutes earlier. A CoA chromatogram that shows two peaks of comparable intensity may indicate partial decomplexation rather than impurity; comparison to the release-test chromatogram resolves the question. The visual cues for reading a chromatogram of this kind are covered in our CoA reading guide.
Mass spectrometry
Theoretical mass for the Cu²⁺ complex is 402.91 g/mol against the observed monoisotopic mass on ESI-MS. The Cu²⁺ counts as part of the analyzed mass — net peptide content on the CoA reflects this. A CoA listing only free GHK mass (340.38) for a product sold as "GHK-Cu" is a paperwork mismatch and should prompt a question to the vendor.
Color in older lots
Lots that have been stored at room temperature for extended periods, or that have seen repeated temperature cycles between freezer and refrigerator, can show partial color loss. This is the visible signature of partial complex dissociation. Faded material is not safely interpretable as "weaker but still active GHK-Cu" — it is a mixture of complex and free peptide whose ratio is no longer known without re-analysis.
GLOW blend considerations
Our GLOW blend combines GHK-Cu with BPC-157 and TB-500 in a single lyophilized vial. The BPC-157 and TB-500 components are stable across a broader pH and reducing-agent window than GHK-Cu; the blend's storage envelope is therefore set by the GHK-Cu component, not the others. Treat the blend's stability rules as identical to standalone GHK-Cu.
Common errors to avoid:
- Mixing GHK-Cu into acidic or reducing-agent-containing buffers. Both dissociate the complex.
- Co-dissolving with cysteine-rich peptides at high concentration. Free cysteine thiols can reduce or chelate the copper.
- Assuming faded color means "older but still good." Color loss is direct evidence of complex degradation.
- Discarding a vial because the lyophilized cake "looks too small." GHK-Cu lyophilizes into a dense, intensely colored film that can appear smaller than expected. The CoA's net peptide content, not visual estimation, is the source of truth.
- Cross-referencing free-GHK literature without checking complex stoichiometry. Many older papers report results in terms of free GHK mass; the molar equivalent in GHK-Cu is different by roughly 18%, and incautious dose conversions silently shift study conditions.
Where to find primary literature
PubMed indexes most of the GHK-Cu preclinical work; search terms "GHK-Cu", "copper tripeptide-1", and "glycyl-histidyl-lysine" together cover the bulk of it. Loren Pickart's group has published the largest single body of work and is a reasonable entry point. Maquart's group at Reims and the more recent Connectivity Map analysis from the Pickart laboratory together cover most of the modern citations. The Pickart 2018 review "GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration" is a useful synthesis of the in vitro fibroblast and dermatology literature through the late 2010s.
